Bristol Myers Squibb have extended their research collaboration aimed at designing and optimizing small-molecule drugs for ...

Spending on healthcare AI has tripled since 2024 as organizations are rapidly adopting domain-specific tools to tackle ...

Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its first external funding round, with the proceeds expected to accelerate its research and ...

Breast and Gynecologic Cancer Care for Sexual Minority Women and Transgender People The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding within Google parent company Alphabet, raising $600 million to advance its ...

When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

When a Ukrainian soldier takes shrapnel from a mine blast or some drone-dropped munition, survival hinges on seconds. Those seconds now belong to artificial intelligence. In the midst of the war with ...

GUEST COMMENTARY—For millions of patients, the slow pace of drug discovery means years – sometimes decades – without effective treatments. Many diseases remain untreatable, not because they are rare ...

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.